Pfizer Posts Earnings Beat Thanks to Solid Vaccine Sales

Pfizer posted an earnings beat in its third quarter, with revenue soaring over 134% thanks to solid Covid-19 vaccine sales. Pfizer also raised its outlook for the full-year, expecting revenue to surpass $80 billion. Peter Andersen, CEO & founder of Andersen Capital Management, joined Cheddar Movers to discuss.
More Videos
CES 2025: Top Tech to Watch
Jason Hiner, Editor in Chief of ZDNET, breaks down the best tech that came out of CES 2025, including Nvidia's Cosmos, New TV Tech, Roborok Saros Z70 and more.
Load More